Skip to Main Content

WASHINGTON — A top FDA official known for speaking out against controversial drug approval decisions, Ellis Unger, retired this week, he told STAT.

Unger, a 25-year veteran of the FDA, served as the head of the FDA’s Office of Drug Evaluation-I, an office that reviewed drugs for a range of conditions from high cholesterol to Alzheimer’s and depression.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment